Shelton Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-282,100
| Closed | -$1.64M | – | 717 |
|
|
2022
Q3 | $1.64M | Sell |
282,100
-47,900
| -15% | -$278K | 0.08% | 210 |
|
|
2022
Q2 | $1.46M | Buy |
330,000
+230,000
| +230% | +$1.02M | 0.07% | 229 |
|
|
2022
Q1 | $910K | Sell |
100,000
-35,000
| -26% | -$319K | 0.03% | 274 |
|
|
2021
Q4 | $2.76M | Hold |
135,000
| – | – | 0.1% | 205 |
|
|
2021
Q3 | $3.45M | Buy |
135,000
+44,000
| +48% | +$1.12M | 0.13% | 166 |
|
|
2021
Q2 | $3.18M | Buy |
91,000
+29,000
| +47% | +$1.01M | 0.12% | 182 |
|
|
2021
Q1 | $2.07M | Buy |
62,000
+43,000
| +226% | +$1.43M | 0.07% | 234 |
|
|
2020
Q4 | $493K | Buy |
+19,000
| New | +$493K | 0.02% | 342 |
|